HrHPV-testing in a university hospital gynecology outpatient clinic: recommendations for clinical practice.

Abstract

The high (>2%) cumulative 18-month CIN2/3+ risk in patients with presumed cervical and/or endometrial pathology warrants routine cervical testing.

In these women a hrHPV-test should be added to cytology because this identifies a significant number of additional women with a substantial risk of CIN2/3+ lesions who would not be identified with cytology alone.

Women referred for other reasons should not have cervical testing beforehand, because of their low risk of CIN2/3+.

Full Text

• DOI - Gynecologic oncology (DOI)
• Swets Information Services - full-text online
• OhioLINK Electronic Journal Center - full-text online
• Elsevier Science - full-text online
• EBSCO - full-text online

Subjects

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• Ambulatory Care
• Cervical Intraepithelial Neoplasia
• Cervix Uteri
• Cohort Studies
• Female
• Follow-Up Studies
• Gynecology
• Hospitals, University
• Humans
• Middle Aged
• Papillomaviridae
• Papillomavirus Infections
• Uterine Cervical Neoplasms
• Young Adult

Similar articles

• High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology. (2012-06-19)
• Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. (2013-03-28)
• CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease. (2013-03-02)
• Colposcopy referral rate can be reduced by high-risk human papillomavirus triage in the management of recurrent atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion cytology in Finland. (2012-07-30)
• Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. (2011-12-22)
• Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months. (2007-05-24)
• Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. (2012-10-02)
• Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening. (2008-02-07)
• Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. (2012-08-03)

Authors

• J A Louwers
• J Berkhof
• A Zaal
• M Kocken
• L Rozendaal
• D A M Heideman
• W M van Baal
• P J F Snijders
• R H M Verheijen
• C J L M Meijer

Publication date

2012-02-13

Journal

Journal topics

• Genital Neoplasms, Female

Language

Eng.

Copyright

Gynecologic oncology

VU University Medical Center, Department of Pathology, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands. ja.louwers [at] vumc.nl

Release reference

Gynecol Oncol. 2012 Mar;124(3):518-24

Related books

• Books of Ambulatory Care
• Books of Cervical Intraepithelial Neoplasia
• Books of Cervix Uteri
• Books of Cohort Studies
• Books of Follow-Up Studies
• Books of Genital Neoplasms, Female
• Books of Gynecology
• Books of Hospitals, University
• Books of Papillomaviridae
• Books of Papillomavirus Infections
• Books of Uterine Cervical Neoplasms